In contrast, LECs isolated from the livers of patients with obesity associated NASH, upregulated genetic programs related to downstream cholesterol signaling and IL13 signaling, potentially through the upregulation of CD36 and p38 mitogen activated protein kinase (MAPK) (Tamburini et al., 2019). The gene discussed is IL13; the disease is metabolic dysfunction-associated steatohepatitis.